New Treatments & Clinical Trials for Sepsis

Sepsis is a life-threatening condition where the body's response to infection causes widespread inflammation and organ damage. It kills over 270,000 people annually in the U.S. and is the most expensive condition treated in hospitals. Current care centers on early antibiotics, fluids, and organ support, but about one in six hospitalized sepsis patients dies.

What's actually going on in research

Trials are testing drugs that calm specific parts of the immune response without shutting down infection-fighting entirely, antibodies that block bacterial toxins, and ways to identify which patients need which treatment. Researchers are also studying sepsis that happens outside hospitals, long-term effects in survivors, and whether earlier detection through monitoring technology can prevent deaths.

What to know before you search

Eligibility typically depends on sepsis severity, organ dysfunction, time since diagnosis, and whether the infection source is known.

What types of trials are currently open

• Treatment trials — Testing drugs that modulate the immune response or target specific sepsis mechanisms, usually given alongside standard antibiotics and supportive care.
• Biomarker trials — Studies developing blood tests to identify sepsis subtypes or predict which patients will deteriorate, aiming to guide personalized treatment.
• Early detection studies — Testing monitoring systems that use vital signs and lab values to catch sepsis earlier, before organs fail.
• Supportive care trials — Comparing different approaches to fluid resuscitation, blood pressure support, and organ support in the ICU.
• Recovery studies — Following sepsis survivors to understand long-term complications and test interventions that might improve cognitive function, physical recovery, or prevent recurring infections.